Morton, United Kingdom

Peter Timmins

This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Timmins. Retrieved from https://idiyas.com/inventor/peter-timmins-jkfdyae8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Morton, Wirral, Merseyside, GB (1989)
  • Irby, Wirral, Merseyside, L61 4YP, GB (1989)

Company Filing History:

goldMedal2 out of 834,513 
Other
 patents

Years Active: 1989

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Peter Timmins

Introduction

Peter Timmins is a notable inventor based in Morton, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-fungal agents and steroid formulations. With a total of 2 patents to his name, Timmins continues to push the boundaries of innovation in his area of expertise.

Latest Patents

Timmins' latest patents include a complex of anti-fungal agent and cyclodextrin and a steroid cream formulation. The anti-fungal complex is formed of a polyene anti-fungal agent, such as amphotericin B, and cyclodextrin, preferably gamma-cyclodextrin. This complex demonstrates improved water solubility and stability compared to prior art amphotericin B anti-fungal agents. The method for forming this complex involves dissolving the anti-fungal agent in an aqueous solution of cyclodextrin at a pH ranging from about 9 to about 12, and maintaining the resulting solution at a pH of about 6 to about 8. The solution can be lyophilized to achieve higher solubility.

The steroid cream formulation consists of (11.beta.,17.alpha.)-17-(ethylthio)-9.alpha.-fluoro-11.beta.-hydroxy-17-(methylthio)androsta-1,4-dien-3-one (tipredane) and a vehicle containing major ingredients such as propylene glycol and water. This formulation is designed to have enhanced physical and chemical stability, with a buffer to impart an acid value greater than 3, and includes a high melting point wax to maintain proper consistency without adversely affecting the stability of tipredane.

Career Highlights

Throughout his career, Peter Timmins has focused on creating innovative solutions in the pharmaceutical industry. His work has led to advancements that improve the efficacy and stability of various formulations, making a significant impact on patient care.

Collaborations

Timmins has collaborated with notable colleagues, including Wing-Sun Chow and Shirley C Chen. These partnerships have contributed to the development of his innovative patents and have fostered a collaborative environment for research and development.

Conclusion

Peter Timmins is a distinguished inventor whose work in pharmaceuticals has led to valuable innovations. His patents reflect a commitment to improving medical formulations, showcasing his expertise

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…